Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients.

MLA

Wang, Julie, et al. “Overall Haemostatic Potential (OHP) Assay Can Risk Stratify for Venous Thromboembolism Recurrence in Anticoagulated Patients.” Journal of Thrombosis and Thrombolysis, vol. 55, no. 1, Jan. 2023, pp. 32–41. EBSCOhost, https://doi.org/10.1007/s11239-022-02686-6.

APA

Wang, J., Lim, H. Y., Brook, R., Lai, J., Nandurkar, H., & Ho, P. (2023). Overall haemostatic potential (OHP) assay can risk stratify for venous thromboembolism recurrence in anticoagulated patients. Journal of Thrombosis and Thrombolysis, 55(1), 32–41. https://doi.org/10.1007/s11239-022-02686-6

Chicago

Wang, Julie, Hui Yin Lim, Rowena Brook, Jeffrey Lai, Harshal Nandurkar, and Prahlad Ho. 2023. “Overall Haemostatic Potential (OHP) Assay Can Risk Stratify for Venous Thromboembolism Recurrence in Anticoagulated Patients.” Journal of Thrombosis and Thrombolysis 55 (1): 32–41. doi:10.1007/s11239-022-02686-6.